Interventional Cardiology Market Size, Share, Current Status, Analysis, Trend and Forecasts 2027


 Cardiac disorder remains one of the significant reasons behind the soaring number of deaths worldwide. The World Health Organization reveals that annually, CVDs or cardiovascular diseases claim around 17.9 million lives across the globe. Surging cases of arrhythmias as well as heart failures have fostered the demand for highly advanced interventional cardiology devices.   A prominent trend rapidly emerging in the global market include the augmented preference for bioresorbable stents in the healthcare industry.

Increasing life expectancy along with frequent technological advances will ensure that interventional cardiology Industry Insights notes sustained demand throughout the review timeframe. Factors including rising prevalence of unhealthy lifestyle, innovations in cardiac devices, mounting awareness and the accelerated number of healthcare programs should further enhance the market size. Underdeveloped regions have vast unmet medical requirements, which can be a striking opportunity for global manufacturers in the market. Favorable insurance scenario encourages patients to opt for treatment, especially in countries like Canada, US, and the UK, and could be favorable for the worldwide industry in subsequent years.

Interventional cardiology market was worth USD 15,130.75 Million in the year 2018, says Market Research Future (MRFR). MRFR expects the global market size to expand at a rate of 7.25% between 2020 and 2027.

Key Players

Eminent players profiled in the global interventional cardiology market report include W. L. Gore & Associates, Inc. (US), Terumo Corporation (Japan), Merit Medical Systems, Inc (US), Medtronic (Ireland), Life Vascular Devices Biotech S.L. (Spain), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Edwards Lifesciences Corporation (US), Cook Medical (US), Cardinal Health (US), Boston Scientific Corporation (US), Biotronik SE & Co. KG (Germany), Biosense Webster, Inc (US), BD (US), B. Braun Melsungen AG (Germany), ACIST Medical Systems, Inc. (the US), Abbott (US), and ABIOMED (US).

Segmentation 

The Market Research Future Report provides an inclusive segmental analysis of the global interventional cardiology market based on end user and type. 

  • By Type, the interventional cardiology market is segmented into coronary guidewires, plaque modification devices, percutaneous transluminal coronary angioplasty (PTCA) catheters, stents, and accessories. Stents are again segmented into bioresorbable vascular scaffolds, bare-metal stents, and drug-eluting stents. PTCA catheters are again segmented into guiding catheters and balloon catheters. Of these, the stents segment will lead the market over the forecast period for the rising number of product launches by industry players lately, constant innovation by players, and rising cases of coronary artery disease. 
  • By End user, the interventional cardiology market is segmented into ambulatory surgical centers, cardiac catheterization laboratories, hospitals, and others. Of these, hospitals will spearhead the market over the forecast period for the increase in patient admissions in hospitals for coronary diseases. This will be followed by the cardiac catheterization laboratory segment, which is likely to grow at a fast pace for its rising preference by medical professionals.

Regional Analysis 

The regional study of the interventional cardiology industry comprises Europe, Asia Pacific or APAC, the Americas and MEA or Middle East and Africa.

Americas has landed the leading spot in the global market as the region is witnessing a spike in the number of coronary disorders. Percutaneous coronary intervention is a common medical procedure carried out in the region, aimed at patients suffering from coronary artery disease. The escalating demand for interventional cardiology can be accredited to the sizeable investments made by major manufacturers in the region, trying to widen their customer base. Additionally, the rapidly burgeoning cardiac patient pool, sophisticated healthcare system, and the extensive adoption of state-of-the-art healthcare technologies within the cardiac field will also warrant significant gains for the American market over the following years.

Europe is the second highest revenue generating market, due to the government spending substantially on the development and upgradation of the healthcare industry. Noteworthy increase in the number of research & development activities, growth in cardiac surgeries amidst the evolving lifestyle of the mass is anticipated to benefit the European industry in the years ahead.

APAC is bound to make progress at the fastest pace during the given period, on account of the escalation in the cases of cardiac ailments as well as the surging expenditure aimed at improving the healthcare infrastructure. Burgeoning geriatric patient pool and the rising emphasis on business expansion among the regional players also strengthens the APAC market’s position.   

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future (MRFR) team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. 

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited), 

99 Hudson Street,5Th Floor, New York, New York 10013, 

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Comments

Post a Comment

Popular posts from this blog

3D Bioprinting Market Company Profile and Segments Poised for Strong Growth in Future 2030

  3D Bioprinting is a process used during which soft, living tissue with the consistency of jelly or putty is printed in a structure resembling organs and body parts at much higher speeds and more efficiently than can be done by the body itself. As printing uses new technology in the future, 3D bioprinting is going to completely transform the healthcare industry. It has been around for over 10 years now and is still continuously progressing to make more advanced versions that can be used in multiple other fields such as electronics, automotive, aerospace industries. Next generation bioprinting process uses stem cells instead of plastic or metal resins thus facilitating regenerative medicine therapy. This report will not only provide an in-depth study of the Global  3D Bioprinting Market  but it will also offer a deep insight on what the market's future looks like.The global bio-printing market is expected to reach $2.2 billion, and it alone can provide opportunities worth...
Read more

Medical Billing Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast to 2027

Image
  Medical bills are a major pain point for most patients as many struggle to understand, track, manage and pay medical bills. Medical expense providers also have to shoulder much of the burden of the flawed system which has led to poor repayment rates, uncoordinated communications, and patient confusion. High-deductible health plans have been known to aggravate the problem.  Medical billing market  is expanding as the demand for streamlined billing experience is on the rise.  Healthcare bill payments are being made more manageable by medical billing services that use business management software and other technologies to making medical billing a better experience for everyone. Considering that 72% of patients are confused by their EOB or explanation of benefits and 70% of patients are confused by their medical bills, medical billing market is expected to witness an expanded growth scope as managing healthcare costs is a priority for patients, payers as well as the go...
Read more

Controlled Release Drug Delivery Market to Represent Significant Revenue Growth Forecast to 2027

Image
  The controlled release drug delivery market is growing rapidly over the past few years. Increasing prevalence of chronic diseases and increasing government regulation to prevent overdose effects act as a significant driving force pushing up the market growth. Furthermore, the growing geriatric and pediatric population is creating huge market demand. Moreover, the advantages that these controlled release drug delivery systems offer accelerate the growth of the market. According to Market Research Future (MRFR), the global  controlled release drug delivery market  is expected to create a valuation of over USD 70.15 BN by 2023, growing at a double-digit CAGR of 14 % during the review period (2018 – 2023). Technological advancements, improved outcomes & patients' experience, beneficial reimbursement policies, and increasing awareness towards healthcare are other key factors impacting the market growth, positively. On the other hand, some limitations associated with the ...
Read more